OPTN and ovarian carcinoma: This study firstly demonstrates that EEF1D/PI3K/OPTN/Akt is a novel chemotherapy resistant pathway of ovarian cancer, which partially addresses the molecular mechanism of ovarian cancer chemotherapy-resistance.